Manulife (MFC.TO, TSX) C$51.57 on 09 Feb 2026: Q4 earnings on 11 Feb may shift dividend view

Market closed: Manulife (MFC.TO) finished the session at C$51.57 on 09 Feb 2026 as investors position ahead of Q4 results due 11 Feb 2026. The stock trades near its 50-day average of C$50.41 and shows a year-to-date gain of 3.55%. This article focuses on MFC.TO stock ahead of the earnings report, highlighting EPS, dividend signals, analyst targets and short-term technicals to help frame the trading catalyst.

MFC.TO stock: price, volume and session summary

Manulife (MFC.TO) closed at C$51.57 with a 1-day change of -0.77% and volume of 10,201,981 shares. The session high was C$52.12 and low C$51.50, with the 52-week range C$36.93–C$52.97. The market cap stands at CAD 86.88B, reflecting broad institutional ownership and recent upgrades in analyst coverage.

Earnings spotlight: what to watch in the Q4 report

Earnings are due on 11 Feb 2026 and investors will watch EPS drivers and the dividend outlook closely. Manulife reports trailing EPS of 3.12 and a trailing PE of 16.53, so renewed operating leverage or capital deployment comments could move the shares. Expect management commentary on Asia margins, wealth flows and capital returns to be the immediate market triggers.

Fundamentals and valuation: MFC.TO stock metrics

Key ratios show solid cash generation: operating cash flow per share C$18.06, book value per share C$31.24, and tangible book C$24.77. Price-to-book is 1.70 and price-to-sales is 1.74, below the Financial Services sector average PB of 1.74 and PE average of 13.37. The dividend pays C$1.76 annually, a yield near 3.41%, with a payout ratio of 55.22%, signaling a balance between income and retained capital for growth.

Meyka AI grade and technical snapshot

Meyka AI rates MFC.TO with a score out of 100: 76.04 (Grade B+), suggestion BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Technicals show RSI 69.10, ADX 30.55 (strong trend) and MACD histogram 0.12, indicating momentum but limited near-term overbought risk.

Analyst views, price targets and recent news

Wall Street consensus sits near C$51.50 and recent broker targets range around C$52.00 after positive commentary from major banks. News flow includes institutional stake moves and a recent dividend increase that supports yield-focused flows. For primary sources, see the MarketBeat analyst note and Investing historical summary for context source source.

Risks, sector context and catalysts

Key risks include insurance reserve shocks, weaker Asia wealth flows, and interest rate shifts that affect spreads. The Financial Services sector shows a 1Y performance of 23.50%, and Manulife’s diversified mix gives it a relative edge versus peers. Near-term catalysts: Q4 results on 11 Feb 2026, guidance update, and any change to buyback or dividend policy.

Final Thoughts

MFC.TO stock sits at C$51.57 on 09 Feb 2026 with a clear earnings catalyst on 11 Feb 2026. Meyka AI’s forecast model projects a 12-month target of C$55.63, implying a 7.88% upside versus the current price, though forecasts are model-based projections and not guarantees. Our analysis highlights healthy cash flow metrics, a 3.41% yield and a B+ Meyka grade driven by solid ROE and operating cash flow. Watch EPS momentum, Asia margins and capital return commentary in the Q4 release. Traders should balance the forecast upside against reserve and macro risks. For quick reference, see analyst targets near C$51.50–C$52.00 and the Meyka technical signals that show momentum but some near-term overbought readings. Meyka AI provides this AI-powered market analysis to help frame the trade, not as financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.